Paradromics, a neurotech company, has successfully implanted its brain-computer interface (BCI) into a human brain, signalling its clinical-stage transitions. The Connexus BCI system was tested safely in a patient undergoing epilepsy surgery. Paradromics aims to provide communication abilities to those with severe motor impairments. Formal clinical trials, pending FDA approval, are planned for later this year.
Paradromics, a neurotech company, has successfully implanted its brain-computer interface (BCI) into a human brain, signalling its clinical-stage transitions. The Connexus BCI system was tested safely in a patient undergoing epilepsy surgery. Paradromics aims to provide communication abilities to those with severe motor impairments. Formal clinical trials, pending FDA approval, are planned for later this year.